Spruce Biosciences Inc (SPRB) volume exceeds 24.32 million: A new investment opportunity for investors

Sana Meer

Spruce Biosciences Inc (NASDAQ: SPRB) kicked off on Monday, up 1378.46% from the previous trading day, before settling in for the closing price of $8.82. Over the past 52 weeks, SPRB has traded in a range of $4.28-$45.60.

During the last 5-year period, the sales drop of Healthcare Sector giant was -16.93%. While this was happening, its average annual earnings per share was recorded 97.07%. With a float of $0.47 million, this company’s outstanding shares have now reached $0.56 million.

Spruce Biosciences Inc (SPRB) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Spruce Biosciences Inc is 17.40%, while institutional ownership is 9.98%.

Spruce Biosciences Inc (SPRB) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -15.75 earnings per share (EPS), higher than consensus estimate (set at -17.63) by 1.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.55 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 97.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 52.27% during the next five years compared to -16.93% drop over the previous five years of trading.

Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators

Take a look at Spruce Biosciences Inc’s (SPRB) current performance indicators. Last quarter, stock had a quick ratio of 2.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 56.52.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -85.92, a number that is poised to hit -15.56 in the next quarter and is forecasted to reach -11.31 in one year’s time.

Technical Analysis of Spruce Biosciences Inc (SPRB)

Looking closely at Spruce Biosciences Inc (NASDAQ: SPRB), its last 5-days average volume was 5.01 million, which is a jump from its year-to-date volume of 0.14 million. As of the previous 9 days, the stock’s Stochastic %D was 58.10%.

During the past 100 days, Spruce Biosciences Inc’s (SPRB) raw stochastic average was set at 76.09%, which indicates a significant increase from 75.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 10.88 in the past 14 days, which was higher than the 2.34 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $11.26, while its 200-day Moving Average is $15.93. However, in the short run, Spruce Biosciences Inc’s stock first resistance to watch stands at $190.26. Second resistance stands at $250.11. The third major resistance level sits at $330.23.

Spruce Biosciences Inc (NASDAQ: SPRB) Key Stats

The company with the Market Capitalisation of 73.48 million has total of 562K Shares Outstanding. Its annual sales at the moment are 4,910 K in contrast with the sum of -53,040 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -14,040 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.